According to MedImmune, the AstraZeneca subsidiary that makes FluMist, studies have shown that people ages 18 to 49 can successfully give the vaccine, and it's just as effective as having a doctor ...
( MENAFN - PR Newswire) NEW YORK, Sept. 23, 2024 /PRNewswire/ -- MTS health Partners ("MTS") announced today that healthcare investment banker Aaron Schwimmer has joined their global life sciences ...